Paper: https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2.full.pdf+html https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v... Op ed: https

Paper: https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2.full.pdf+html https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v... Op ed: https://www.nytimes.com/2020/07/03/opinion/coronavirus-tests.html https://www.nytimes.com/2020/07/03/opinion/coronavirus-tests... This isn’t like PCR testing. It’s closer to insulin testing, in terms of the expense and difficulty of creation of the tests (and the means of interpreting the results). 350M is well within the range of possibility. And the reward to having a reopened economy and significantly reduced death toll could justify very large investment.